Understanding how peptides interact with menopause-related weight changes helps women anticipate and manage the additional challenges of switching medications during this life phase
the appetite-suppressing effects of GLP-1 agonists require careful consideration Medication absorption : Delayed gastric emptying may theoretically affect the absorption of oral Crohn's disease medications, though clinical significance remains unclear Ongoing monitoring strategies include: Symptom diary : Patients should maintain records distinguishing new gastrointestinal symptoms from their baseline Crohn's pattern Faecal calprotectin testing : When clinically indicated to differentiate inflammatory activity from functional symptoms, in line with NICE DG11 guidance Nutritional surveillance : Regular assessment of weight, body composition, and nutritional markers (albumin, vitamins, minerals) Dose titration : Slower than standard dose escalation may improve gastrointestinal tolerability Collaborative care between gastroenterology and diabetes/obesity services is strongly recommended
YOU SHOULD CONSULT WITH YOUR PHYSICIAN BEFORE ADDING ANYTHING TO YOUR DAILY REGIMEN
GLP-1 is a hormone that is naturally secreted by the intestines and plays a role in controlling hunger levels, blood sugar regulation, and the digestive process
To prevent fragmentation and breakdown of peptides, use 1 to 2.5 ml of solution for reconstitution unless related studies confirm that a higher volume is safe
It extends its peak and prolongs the half-life of elevated GH levels
